secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aterian, Inc. (ATER)
CIK:        0001757715
Form:       8-K
Filed at:   2026-09-08T20:25:00+00:00
Accession:  0001437749-26-029837
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aterian receives Nasdaq bid price deficiency notice; CFO terminated, CEO interim CFO
--------------------------------------------------------------------------------

- Nasdaq notified Aterian of non-compliance with $1.00 min bid price rule; 180-day cure period until March 1, 2027.
- CFO Joshua Feldman terminated Sep 4, 2026 per transition agreement; receives severance benefits.
- CEO David E. Lazar named interim CFO while company searches for full-time replacement.
- Company may face delisting if not compliant by March 1, 2027; could get second 180-day period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757715/000143774926029837/0001437749-26-029837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757715/000143774926029837/ater20260902_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-029837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer